XIAMEN, CHINA, September 14, 2021 -- The city of Xiamen in Southeast China's Fujian Province started the city-wide nucleic acid testing for COVID-19. In response, MGI urgently deployed 50 automation systems from all over the country to Xiamen overnight and gathered a group of after-sales engineers with frontline experience to . "To , MGI deployed its proprietary automation systems to Xiamen overnight, including MGISTP-7000 High-throughput Automated Sample Transfer Processing System, MGISP-NE384...

NANNING, CHINA, September 10-13, 2021 - MGI showcased a series of innovative platforms at the 18th China-ASEAN Expo on Sep.10th in Nanning, China. MGI exhibited multiple platforms including: MGI's proprietary platforms and technologies made a successful appearance at the 18th China-ASEAN Expo and attracted great attention from the mainstream Chinese media, including and . "We are committed to upgrading our innovative platforms to standardize diagnostic testing labs with higher data capacity and...

Recently, MGI's proprietary high-throughput genetic sequencer DNBSEQ-T7*, was officially delivered to GrandOmics. With the support of DNBSEQ-T7*, GrandOmics aims to become a leading provider of long-read and short-read sequencing service, and further consolidate its innovative development in sequencing services and precision medicine. Long-read and short-read sequencing technologies will jointly promote the innovative development of GrandOmics' business. GrandOmics has accumulated extensive pr...

Shenzhen, China, 27 August 2021 - MGI and Molbreeding Biotech Co., Ltd. (Molbreeding) officially formed strategic cooperation in Molecular Breeding. Under the partnership, the two parties will join hands to develop more molecular breeding applications and products based on MGI's DNBSEQ-T7 ultra-high throughput sequencing platform, to promote the innovation and industrialization of animal and plant molecular breeding in China. Enhancing genetic detection capacity with lower cost to improve the ...

MGIUS-R3 Robotic Ultrasound System was selected for 17 pilot projects covering 4 categories including 5G+Emergency Treatment, 5G+Remote Diagnosis, 5G+Remote ICU and 5G+Healthcare Management. 5G + Emergency Treatment●Under this Category, the MGI system was successfully selected for the 5G+ Plateau emergency treatment project. 5G+Remote Diagnosis●Under the 5G+ Remote Diagnosis category, MGI system was selected for a total of 14 5G+ Remote Ultrasound Robot related projects that were initiated b...

On August 10, China Health Commission issued Notice on Further Strengthening the Organization and Management of Nucleic Acid Testing for All Staff (the Notice) in response to the COVID-19 pandemic control and prevention. "We have greatly upgraded the performance of automation equipment and accumulated extensive frontline experience, making it possible to provide urgent support for large-scale nucleic acid testing." Lin Siyuan, Director of Mobile Lab at MGI. "It will take 42 MGISTP-7000 High-th...